ESC Professional Premium Access

Lipid-lowering therapy and the atheroma

Event: ESC Congress 2022
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Session type: Advances in Science
Date: 26 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

State-of-the-art lecture in lipid lowering therapy and the atheroma .

Speaker: Professor S. Nicholls (Melbourne, AU)
Thumbnail

Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: Further insights from the ODYSSEY OUTCOMES trial

Speaker: Doctor S. Goodman (Toronto, CA)
Thumbnail

Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: Insights from the PACMAN-AMI randomized trial

Speaker: Doctor K. Koskinas (Bern, CH)
Thumbnail

3 speakers from this session

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
36 presentations
2 followers

Doctor Shaun Goodman

St. Michael's Hospital, Toronto (Canada)
1 presentation
0 follower

Doctor Konstantinos Koskinas

Bern University Hospital, Inselspital, Bern (Switzerland)
6 presentations
0 follower

This platform is supported by

logo Novo Nordisk